Perilesional injections of human platelet lysate versus platelet poor plasma for the treatment of diabetic foot ulcers: A double‐blinded prospective clinical trial

Diabetic foot ulcer (DFU) is a major cause of morbidity, non‐traumatic lower limb amputation in diabetic patients and a high‐cost burden on the healthcare system. New therapeutic products are increasingly tested. Platelet‐rich plasma (PRP) and human platelet lysate (hPL) are reported to be useful. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhawari, Hussam, Jafar, Hanan, Al Soudi, Mohammad, Ameereh, Lena Abu, Fawaris, Maram, Saleh, Mohanad, Aladwan, Safwan, Younes, Nidal, Awidi, Abdalla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502275/
https://www.ncbi.nlm.nih.gov/pubmed/37140065
http://dx.doi.org/10.1111/iwj.14186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502275/
https://www.ncbi.nlm.nih.gov/pubmed/37140065
http://dx.doi.org/10.1111/iwj.14186

Ejemplares similares